The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N.C. Boyd, Geert Kazemier, Elisa Giovannetti et al.|Cancers|2022Cited by 41
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood BiomarkersLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|JAMA Network Open|2023Cited by 17
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N.C. Boyd, Heinz‐Josef Klümpen, Lynn E. Nooijen et al.|Frontiers in Pharmacology|2023Cited by 10
Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancerLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|The Journal of Liquid Biopsy|2024Cited by 4
hENT1 as a Predictive Biomarker in PDAC—LetterLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|Clinical Cancer Research|2023Cited by 2